[HTML][HTML] Next generation sequencing and the future of genetic diagnosis
The introduction of next generation sequencing (NGS) has led to an exponential increase of
elucidated genetic causes in both extremely rare diseases and common but heterogeneous …
elucidated genetic causes in both extremely rare diseases and common but heterogeneous …
Sanfilippo syndrome: consensus guidelines for clinical care
N Muschol, R Giugliani, SA Jones, J Muenzer… - Orphanet Journal of …, 2022 - Springer
Sanfilippo syndrome is a group of rare, complex, and progressive neurodegenerative
lysosomal storage disorders that is characterized by childhood dementia. The clinical …
lysosomal storage disorders that is characterized by childhood dementia. The clinical …
Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial
M Tardieu, M Zérah, ML Gougeon, J Ausseil… - The Lancet …, 2017 - thelancet.com
Background Mucopolysaccharidosis type IIIB syndrome (also known as Sanfilippo type B
syndrome) is a lysosomal storage disease resulting in progressive deterioration of cognitive …
syndrome) is a lysosomal storage disease resulting in progressive deterioration of cognitive …
Diagnosis of mucopolysaccharidoses
F Kubaski, F de Oliveira Poswar, K Michelin-Tirelli… - Diagnostics, 2020 - mdpi.com
The mucopolysaccharidoses (MPSs) include 11 different conditions caused by specific
enzyme deficiencies in the degradation pathway of glycosaminoglycans (GAGs). Although …
enzyme deficiencies in the degradation pathway of glycosaminoglycans (GAGs). Although …
Clinical presentation and diagnosis of mucopolysaccharidoses
M Stapleton, N Arunkumar, F Kubaski… - Molecular genetics and …, 2018 - Elsevier
Mucopolysaccharidoses (MPS) are estimated to affect1 in 25,000 live births although
specific rates vary between the ethnic origin and country. MPS are a group of lysosomal …
specific rates vary between the ethnic origin and country. MPS are a group of lysosomal …
Targeted enrichment of the black cottonwood (Populus trichocarpa) gene space using sequence capture
L Zhou, JA Holliday - BMC genomics, 2012 - Springer
Background High-throughput re-sequencing is rapidly becoming the method of choice for
studies of neutral and adaptive processes in natural populations across taxa. As re …
studies of neutral and adaptive processes in natural populations across taxa. As re …
Mukopolysaccharidosen
J Spranger - Pädiatrie: Grundlagen und Praxis, 2020 - Springer
Mukopolysaccharidosen (MPS) sind erbliche, progrediente Speicherkrankheiten,
hervorgerufen durch die intrazelluläre Anhäufung von Glykosaminoglykanen (sauren …
hervorgerufen durch die intrazelluläre Anhäufung von Glykosaminoglykanen (sauren …
The attenuated end of the phenotypic spectrum in MPS III: from late-onset stable cognitive impairment to a non-neuronopathic phenotype
SCM Nijmeijer, LI van den Born, AJA Kievit… - Orphanet journal of rare …, 2019 - Springer
Background The phenotypic spectrum of many rare disorders is much wider than previously
considered. Mucopolysaccharidosis type III (Sanfilippo syndrome, MPS III), is a lysosomal …
considered. Mucopolysaccharidosis type III (Sanfilippo syndrome, MPS III), is a lysosomal …
Adult-onset painful axonal polyneuropathy caused by a dominant NAGLU mutation
M Tétreault, M Gonzalez, MJ Dicaire, P Allard… - Brain, 2015 - academic.oup.com
Late-onset painful sensory neuropathies are usually acquired conditions associated with
common diseases. Adult presentations of known hereditary forms are often accompanied by …
common diseases. Adult presentations of known hereditary forms are often accompanied by …
Residual N‐acetyl‐α‐glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIB
OLM Meijer, L Welling, MJ Valstar… - Journal of Inherited …, 2016 - Wiley Online Library
Abstract Background Mucopolysaccharidosis type IIIB (MPS IIIB) is a rare genetic disorder in
which the deficiency of the lysosomal enzyme N‐acetyl‐α‐glucosaminidase (NAGLU) …
which the deficiency of the lysosomal enzyme N‐acetyl‐α‐glucosaminidase (NAGLU) …